CN1119944A - Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither - Google Patents

Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither Download PDF

Info

Publication number
CN1119944A
CN1119944A CN94104944A CN94104944A CN1119944A CN 1119944 A CN1119944 A CN 1119944A CN 94104944 A CN94104944 A CN 94104944A CN 94104944 A CN94104944 A CN 94104944A CN 1119944 A CN1119944 A CN 1119944A
Authority
CN
China
Prior art keywords
parts
chinese medicine
radix
medicine preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN94104944A
Other languages
Chinese (zh)
Other versions
CN1056516C (en
Inventor
林元森
林盛红
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN94104944A priority Critical patent/CN1056516C/en
Publication of CN1119944A publication Critical patent/CN1119944A/en
Application granted granted Critical
Publication of CN1056516C publication Critical patent/CN1056516C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The Chinese patent medicine in the form of powder, pill or capsule for curing senile and progressive cataract, glaucoma and optic atrophy with efective rate of 90%, cure rate of 65% and short treating course of 1-2 months is prepared from 14 Chinese-medicinal materials such as raw sea-ear shell, rehmannia root, yam, tuckahoe, alismatis rhizome, etc.

Description

The Chinese medicine preparation of treatment cataract, glaucoma, optic atrophy
The present invention relates to a kind of Chinese medicine preparation for the treatment of cataract, glaucoma, optic atrophy ophthalmic.
Eyes are one of vitals of human body, in case generation ophthalmic, all bring many miseries to the patient, especially cataract, glaucoma, optic atrophy are the high ophthalmics of sickness rate, not only bring from vision and be attenuated to blind misery to the patient, and treat this type of disease, still there is not specific drug at present.As to cataract, employing is taken medicine for a long time usually, the development of disease controlling, and the medicine that has is taken too much, also has certain side effect.When uncontrollable, then treat with operation method.The tcm therapy that has, as take the magnetic bead ball, need take half a year to one year (" rural area doctor's handbook is P.474<1969 〉); Take Radix Stephaniae Tetrandrae noctilucence ball, need take 1-2, the phase of taking is long, and its curative effect is all undesirable.To glaucoma, optic atrophy, the effective curable substance of Shang Weijian.
Purpose of the present invention for the misery of removing the patient with carry forward Chinese medical marrow, is researched and developed out a kind of can conveniently taking, and need not operation, can treat the Chinese medicine preparation of cataract, glaucoma, optic atrophy.
On the basis of medicine ancient prescription group agent, filter out fruitful successive dynasties famous expert secret recipe under study for action, in conjunction with present-day medical knowledge with face the medical experience of art, the Chinese prescription that being mainly used in ophthalmics such as treatment cataract has been succeeded in developing in experiment repeatedly.Therefore the contained Chinese prescription composition of Chinese medicine preparation (weight) of treatment cataract of the present invention, glaucoma, optic atrophy is:
Concha Haliotidis 10-30 part Radix Rehmanniae 5-15 part
Radix Rehmanniae Preparata 5-15 part Rhizoma Dioscoreae 5-20 part
Poria 10-20 part Cortex Moutan 10-20 part
Rhizoma Alismatis 10-20 part Fructus Schisandrae Chinensis 3-18 part
Semen Sesami Nigrum 5-15 part Fructus Mori 10-20 part
Fructus Lycii 10-20 part Radix Glycyrrhizae 3-12 part
The powder of Radix Bupleuri 10-20 part Radix Paeoniae Alba 10-20 part.
Its making step is the fine powder that each flavor Chinese medicine powder is broken into 80-100 order (homemade sieve mesh), press the preparation of prescription content and mix, through pulverizing mix homogeneously for the second time, sieve and get the thin medicated powder of 100-120 purpose again, carry out packing by the 30g/ bag, promptly make the cataractous powder medicine of treatment of the present invention.Described operating process must be carried out under aseptic condition.Also powder medicated powder can be added the capsule that adjuvant is made convenient eye usefulness; Can also add Mel and make honeyed pill.
The best composition (weight) of the contained Chinese prescription of Chinese medicine preparation of treatment ophthalmic of the present invention is: 24 parts of Concha Haliotidis, 10 parts in the Radix Rehmanniae, 10 parts in Radix Rehmanniae Preparata, 10 parts of Rhizoma Dioscoreaes, 15 parts in Poria, 15 parts of Cortex Moutans, 15 parts of Rhizoma Alismatis, 6 parts of Fructus Schisandrae Chinensis, 10 parts of Semen Sesami Nigrums, 15 parts of Fructus Mori, 15 parts of Fructus Lycii, 6 parts in Radix Glycyrrhizae, 15 parts of Radix Bupleuri, 15 parts of the Radix Paeoniae Albas.
Instructions of taking with Chinese medicine preparation of the present invention is with powder medicine, brews with 100 ℃ of boiled water and takes after 8-10 minute, can also decoct a drug wrapped better effects if.Its dose is to obey every day three times, each 30g.Generally take medicine and can receive produce effects in 10-20 days, continuous use is about 2 months, and vision can be recovered as ordinary person.Show through clinic trial: still have cataract, optic atrophy, the glaucoma of light sensation that significant effect is arranged with Chinese medicine preparation treatment of the present invention.As be used for the treatment of senile, the cataract patient that sets out in the 1200 routine left and right sides, and effective percentage is more than 90%, and cure rate reaches more than 65%; Optic atrophy 1000 examples, effective percentage can reach 95%, and cure rate is more than 60%; Glaucoma 800 routine effective percentage 90%, cure rate is more than 70%.
Example 1
Take by weighing Concha Haliotidis 12Kg, Radix Rehmanniae 6Kg, Radix Rehmanniae Preparata 6Kg, Rhizoma Dioscoreae 6Kg, Poria 6Kg, Cortex Moutan 6Kg, Rhizoma Alismatis 8Kg, Fructus Schisandrae Chinensis 4Kg, Semen Sesami Nigrum 6Kg, Fructus Mori 6Kg, Fructus Lycii 4Kg, Radix Glycyrrhizae 3Kg, Radix Bupleuri 6Kg, Radix Paeoniae Alba 6Kg pulverize with pulverizer respectively, excessively behind 80 mesh sieves, mixing mixes again and pulverizes, and crosses 100 mesh sieves.Make medicated powder powder.Wrap in aseptic, sanitary condition by 30g/ and carry out packing, promptly make the powder Chinese medicine preparation that clinically to take.
Example 2
Producing powdery powder prescription by example 1 method step is: Concha Haliotidis 24Kg, Radix Rehmanniae 10Kg, Radix Rehmanniae Preparata 10Kg, Rhizoma Dioscoreae 10Kg, Poria 15Kg, Cortex Moutan 15Kg, Rhizoma Alismatis 15Kg, Fructus Schisandrae Chinensis 6Kg, Semen Sesami Nigrum 10Kg, Fructus Mori 15Kg, Fructus Lycii 15Kg, Radix Glycyrrhizae 6Kg, Radix Bupleuri 15Kg, Radix Paeoniae Alba 15Kg.

Claims (5)

1, a kind of Chinese medicine preparation for the treatment of ophthalmic is characterized in that the contained Chinese prescription composition of said preparation (weight) is:
Concha Haliotidis 10-30 part Radix Rehmanniae 5-15 part
Radix Rehmanniae Preparata 5-15 part Rhizoma Dioscoreae 5-20 part
Poria 10-20 part Cortex Moutan 10-20 part
Rhizoma Alismatis 10-20 part Fructus Schisandrae Chinensis 3-18 part
Semen Sesami Nigrum 5-15 part Fructus Mori 10-20 part
Fructus Lycii 10-20 part Radix Glycyrrhizae 3-12 part
The powder of Radix Bupleuri 10-20 part Radix Paeoniae Alba 10-20 part.
2, the Chinese medicine preparation of treatment ophthalmic as claimed in claim 1 is characterized in that described powder can be to add the honeyed pill that Mel is made.
3, the Chinese medicine preparation of treatment ophthalmic as claimed in claim 1 is characterized in that described powder can be to add the capsule that the capsule adjuvant is made.
4, the Chinese medicine preparation of treatment ophthalmic as claimed in claim 1 is characterized in that the best composition (weight) of described preparation is:
10 parts in 24 parts of Radix Rehmanniae of Concha Haliotidis
10 parts of 10 portions of Rhizoma Dioscoreaes of Radix Rehmanniae Preparata
15 parts of 15 parts of Cortex Moutans of Poria
6 parts of 15 parts of Fructus Schisandrae Chinensis of Rhizoma Alismatis
15 parts of 10 parts of Fructus Mori of Semen Sesami Nigrum
6 parts in 15 portions of Radix Glycyrrhizaes of Fructus Lycii
15 parts of 15 portions of Radix Paeoniae Albas of Radix Bupleuri
5, the Chinese medicine preparation of claim 1,2,3,4 treatment ophthalmic is used for the treatment of that cataract, optic nerve contract, glaucoma.
CN94104944A 1994-05-10 1994-05-10 Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither Expired - Fee Related CN1056516C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN94104944A CN1056516C (en) 1994-05-10 1994-05-10 Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN94104944A CN1056516C (en) 1994-05-10 1994-05-10 Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither

Publications (2)

Publication Number Publication Date
CN1119944A true CN1119944A (en) 1996-04-10
CN1056516C CN1056516C (en) 2000-09-20

Family

ID=5031820

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94104944A Expired - Fee Related CN1056516C (en) 1994-05-10 1994-05-10 Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither

Country Status (1)

Country Link
CN (1) CN1056516C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100411660C (en) * 2006-03-09 2008-08-20 北京市眼科研究所 Chinese medicine composition for treating optic atrophy and preparing method therefor
CN104707006A (en) * 2015-03-03 2015-06-17 李军 Radioactive preparation capable of promoting blood circulation and dredging meridians for cataract patients and preparation thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100411660C (en) * 2006-03-09 2008-08-20 北京市眼科研究所 Chinese medicine composition for treating optic atrophy and preparing method therefor
CN104707006A (en) * 2015-03-03 2015-06-17 李军 Radioactive preparation capable of promoting blood circulation and dredging meridians for cataract patients and preparation thereof

Also Published As

Publication number Publication date
CN1056516C (en) 2000-09-20

Similar Documents

Publication Publication Date Title
CN100418571C (en) Medicinal pill for treating cardiovascular and cerebrovascular disease and its preparing process
CN101647947A (en) Mongolian medicinal preparation for treating eye diseases
CN102949540A (en) Traditional Chinese medicinal composite for treating cataract
CN105963411A (en) Traditional Chinese medicine composition for alleviating asthenopia, preparation of traditional Chinese medicine composition and preparation method thereof
CN103735790A (en) Traditional Chinese medicine composition for treating tinnitus
CN101607022B (en) Chinese medicament bone-knitting pellet preparation
CN1056516C (en) Traditional Chinese medicine preparation for treating cataract, glaucoma and optic nerve wither
CN105311383B (en) A kind of health-care Chinese medicinal composition and preparation method thereof of prevention and improvement visual fatigue
CN103285329B (en) Medicament for treating women dysmenorrhea and preparation method thereof
CN1242775C (en) Bushenshansong drink and preparation method thereof
CN1086144C (en) Capsule for tonifying kidney
CN1218708C (en) Chinese medicine prescription for curing eye disease and its preparation method
CN1044326C (en) Facial paralysis pill and applying approach
CN110522815A (en) A kind of Chinese medicine composition and preparation method thereof for treating disease of eye
CN110478442A (en) A kind of Multifunctional eye drops and preparation method thereof
CN100358552C (en) Medicine for treating amblyopia and its preparing method
CN103285128A (en) Traditional Chinese medicine for treating bronchial asthma and preparation method thereof
CN103341014A (en) Drug for invigorating kidney and enhancing sexual function, and preparation method thereof
CN1194733C (en) Medicine for treating hyperthyroidism and its prepn
CN1132095A (en) Nurishing tonic for building body
CN1256958C (en) Miao nationality medicine for treating enuresis and its compounding method
CN101693065A (en) Medicament for treating polymyalgia rheumatica and preparation method thereof
CN102580023A (en) Medicament for treating disorder of spleen and stomach and abdominal swelling and pain
CN1074669C (en) Kidney-nourishing and bone-strengthening pill and its preparation
CN106491730A (en) A kind of treat Chinese medicine composition of glaucoma and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee